Synergy CHC Loses Costco, Its 58% Revenue Customer — Survival at Risk
SNYR is trading near its 52-week low of $0.162 (1.4% below the low) on light trading volume (0.1× avg).
Summary
Synergy CHC Corp. disclosed that Costco will discontinue its FOCUSfactor products, eliminating a customer that represented 58% of 2025 revenue. The company warns of a material adverse effect and is scrambling for financing.
Key Events · Legal and Risk Events · SNYR
-
Costco Discontinues FOCUSfactor
Costco informed Synergy CHC on July 15, 2026 that it will stop carrying the company's FOCUSfactor products, ending a 16-year relationship.
-
58% of Revenue at Risk
Costco accounted for approximately 58% of Synergy CHC's net revenue in fiscal 2025, making this loss potentially devastating to the business.
-
Material Adverse Effect Expected
The company expects the decision to have a material adverse effect on its business, results of operations, liquidity, and financial condition.
-
Urgent Search for Financing
Synergy CHC is evaluating available financing and other strategic alternatives to address the impending revenue shortfall.
Analysis · SNYR · Life Sciences
Costco, which accounted for 58% of Synergy CHC's revenue in fiscal 2025, will stop carrying its FOCUSfactor products. This is a thesis-altering event for a company already burning cash, facing Nasdaq delisting, and reliant on dilutive financing. The loss of its dominant customer threatens the company's viability and forces an urgent search for financing or strategic alternatives.
At the time of this filing, SNYR was trading at $0.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.16 to $3.99. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.